Molecular analyses from a phase I trial of vemurafenib to study mechanism of action (MOA) and resistance in repeated biopsies from BRAF mutation-positive metastatic melanoma patients (pts) Meeting Abstract
| Authors: | McArthur, G. A.; Ribas, A.; Chapman, P. B.; Flaherty, K. T.; Kim, K. B.; Puzanov, I.; Nathanson, K. L.; Lee, R. J.; Koehler, A.; Spleiss, O.; Bollag, G.; Wu, W.; Trunzer, K.; Sosman, J. A. |
| Abstract Title: | Molecular analyses from a phase I trial of vemurafenib to study mechanism of action (MOA) and resistance in repeated biopsies from BRAF mutation-positive metastatic melanoma patients (pts) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880302365 |
| DOI: | 10.1200/jco.2011.29.15_suppl.8502 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8502 -- Source: Wos |
